Home Athenex

Athenex

In operation
IPO
Disease Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Athenex (dba Kinex) is an innovative oncology company with drug discovery, formulation, clinical development, and API/drug manufacturing facilities in both the United States and China. The company aims to improve the lives of cancer patients by creating more effective, safer, and tolerable treatment options.
Athenex, Inc.
Buffalo,NewYork,United States of America
101~500 people
January 01, 2004
info@athenex.com

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Gene Technology Biotechnology
Concept
Disease Treatment Tumor
Application Scenarios
Innovative Drugs